Terms: = Prostate cancer AND DDB2, Q92466, 1643, ENSG00000134574, FLJ34321
28 results:
1. Improved early continence following laparoscopic radical prostatectomy: the urethral hammock technique.
Ortner G; Honis HR; Böhm J; Konschake M; Tokas T; Nagele U
World J Urol; 2024 Mar; 42(1):168. PubMed ID: 38492077
[TBL] [Abstract] [Full Text] [Related]
2. Patient-Reported Outcomes 12 Years after Localized prostate cancer Treatment.
Donovan JL; Hamdy FC; Lane JA; Young GJ; Metcalfe C; Walsh EI; Davis M; Steuart-Feilding T; Blazeby JM; Avery KNL; Martin RM; Bollina P; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Rosario DJ; Rowe E; Mason M; Catto JWF; Peters TJ; Wade J; Turner EL; Williams NJ; Oxley J; Staffurth J; Bryant RJ; Neal DE
NEJM Evid; 2023 Apr; 2(4):EVIDoa2300018. PubMed ID: 38320051
[TBL] [Abstract] [Full Text] [Related]
3. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for prostate cancer.
Hamdy FC; Donovan JL; Lane JA; Metcalfe C; Davis M; Turner EL; Martin RM; Young GJ; Walsh EI; Bryant RJ; Bollina P; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Rosario DJ; Rowe E; Mason M; Catto JWF; Peters TJ; Oxley J; Williams NJ; Staffurth J; Neal DE;
N Engl J Med; 2023 Apr; 388(17):1547-1558. PubMed ID: 36912538
[TBL] [Abstract] [Full Text] [Related]
4. Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort.
Palm A; Theorell-Haglöw J; Isakson J; Ljunggren M; Sundh J; Ekström MP; Grote L
BMJ Open; 2023 Mar; 13(3):e064501. PubMed ID: 36868588
[TBL] [Abstract] [Full Text] [Related]
5. Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients.
Ueda T; Fujita K; Nishimoto M; Shiraishi T; Miyashita M; Kayukawa N; Nakamura Y; Sako S; Ogura R; Fujihara A; Minami T; Hongo F; Okihara K; Yoshimura K; Uemura H; Ukimura O
World J Urol; 2022 Dec; 40(12):2939-2946. PubMed ID: 36331614
[TBL] [Abstract] [Full Text] [Related]
6. Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with
Calais J; Gafita A; Eiber M; Armstrong WR; Gartmann J; Thin P; Nguyen K; Lok V; Gosa L; Grogan T; Esfandiari R; Allen-Auerbach M; Quon A; Bahri S; Gupta P; Gardner L; Ranganathan D; Slavik R; Dahlbom M; Herrmann K; Delpassand E; Fendler WP; Czernin J
J Nucl Med; 2021 Oct; 62(10):1440-1446. PubMed ID: 34016732
[TBL] [Abstract] [Full Text] [Related]
7. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
[TBL] [Abstract] [Full Text] [Related]
8. Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised prostate cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
Neal DE; Metcalfe C; Donovan JL; Lane JA; Davis M; Young GJ; Dutton SJ; Walsh EI; Martin RM; Peters TJ; Turner EL; Mason M; Bryant R; Bollina P; Catto J; Doherty A; Gillatt D; Gnanapragasam V; Holding P; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Altman DG; Hamdy FC;
Eur Urol; 2020 Mar; 77(3):320-330. PubMed ID: 31771797
[TBL] [Abstract] [Full Text] [Related]
9. MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 study.
Ali R; Gabr A; Mouli SK; Kallini JR; Riaz A; Mora R; Lewandowski RJ; Hohlastos E; Casalino DD; Hofer MD; Hamoui N; Miller FH; Hairston J; Salem R
Abdom Radiol (NY); 2019 Feb; 44(2):713-722. PubMed ID: 30196364
[TBL] [Abstract] [Full Text] [Related]
10. Transperitoneal versus extraperitoneal approach in laparoscopic radical prostatectomy: A meta-analysis.
Wang K; Zhuang Q; Xu R; Lu H; Song G; Wang J; Tian Z; Mao Q; Gong P
Medicine (Baltimore); 2018 Jul; 97(29):e11176. PubMed ID: 30024501
[TBL] [Abstract] [Full Text] [Related]
11. Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue.
Keam SP; Gulati T; Gamell C; Caramia F; Arnau GM; Huang C; Schittenhelm RB; Kleifeld O; Neeson PJ; Williams SG; Haupt Y
Radiat Environ Biophys; 2018 Aug; 57(3):241-249. PubMed ID: 29850926
[TBL] [Abstract] [Full Text] [Related]
12. prostate-Specific Antigen-Based Screening for prostate cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
[TBL] [Abstract] [Full Text] [Related]
13. Validating Baboon Ex Vivo and In Vivo Radiation-Related Gene Expression with Corresponding Human Data.
Port M; Majewski M; Herodin F; Valente M; Drouet M; Forcheron F; Tichy A; Sirak I; Zavrelova A; Malkova A; Becker BV; Veit DA; Waldeck S; Badie C; O'Brien G; Christiansen H; Wichmann J; Eder M; Beutel G; Vachelova J; Doucha-Senf S; Abend M
Radiat Res; 2018 Apr; 189(4):389-398. PubMed ID: 29373091
[TBL] [Abstract] [Full Text] [Related]
14. prostate cancer and the John West Effect.
EAU-ESTRO-ESUR-SIOG Prostate Cancer Guidelines Panel
Eur Urol; 2017 Jul; 72(1):7-9. PubMed ID: 28385455
[TBL] [Abstract] [Full Text] [Related]
15. NRIP/DCAF6 stabilizes the androgen receptor protein by displacing ddb2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.
Chen HH; Fan P; Chang SW; Tsao YP; Huang HP; Chen SL
Oncotarget; 2017 Mar; 8(13):21501-21515. PubMed ID: 28212551
[TBL] [Abstract] [Full Text] [Related]
16. Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for prostate cancer.
Donovan JL; Hamdy FC; Lane JA; Mason M; Metcalfe C; Walsh E; Blazeby JM; Peters TJ; Holding P; Bonnington S; Lennon T; Bradshaw L; Cooper D; Herbert P; Howson J; Jones A; Lyons N; Salter E; Thompson P; Tidball S; Blaikie J; Gray C; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Kockelbergh R; Kynaston H; Paul A; Powell P; Prescott S; Rosario DJ; Rowe E; Davis M; Turner EL; Martin RM; Neal DE;
N Engl J Med; 2016 Oct; 375(15):1425-1437. PubMed ID: 27626365
[TBL] [Abstract] [Full Text] [Related]
17. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized prostate cancer.
Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Kockelbergh R; Kynaston H; Paul A; Powell P; Prescott S; Rosario DJ; Rowe E; Neal DE;
N Engl J Med; 2016 Oct; 375(15):1415-1424. PubMed ID: 27626136
[TBL] [Abstract] [Full Text] [Related]
18. Presurgical Biomarker Performance in the Detection of Gleason Upgrading in prostate cancer.
Wittig K; Yamzon JL; Smith DD; Jeske DR; Smith SS
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1643-1645. PubMed ID: 27543619
[TBL] [Abstract] [Full Text] [Related]
19. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
[TBL] [Abstract] [Full Text] [Related]
20. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.
Lane JA; Donovan JL; Davis M; Walsh E; Dedman D; Down L; Turner EL; Mason MD; Metcalfe C; Peters TJ; Martin RM; Neal DE; Hamdy FC;
Lancet Oncol; 2014 Sep; 15(10):1109-18. PubMed ID: 25163905
[TBL] [Abstract] [Full Text] [Related]
[Next]
